首页> Anticancer research> Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.

Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma.

导出原文传递

翻译打印收藏纠错

第一作者： Kyosuke,Agawa

第一单位： Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.

作者： Kyosuke,Agawa ^[1] ; Kimihiro,Yamashita ^[2] ; Akio,Nakagawa ^[3] ; Kouta,Yamada ^[1] ; Akihiro,Watanabe ^[1] ; Junko,Mukohyama ^[4] ; Masafumi,Saito ^[5] ; Mitsugu,Fujita ^[6] ; Gosuke,Takiguchi ^[1] ; Naoki,Urakawa ^[1] ; Hiroshi,Hasegawa ^[1] ; Shingo,Kanaji ^[1] ; Takeru,Matsuda ^[1] ; Taro,Oshikiri ^[1] ; Tetsu,Nakamura ^[1] ; Satoshi,Suzuki ^[1] ; Yoshihiro,Kakeji ^[1]

作者单位： Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan. ^[1] Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan kiyama@med.kobe-u.ac.jp. ^[2] Division of Surgery, Hyogo Prefectural Awaji Medical Center, Awaji, Japan. ^[3] Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.;Department of Pathology and Cell Biology, Department of Medicine (Division of Digestive and Liver Diseases), Herbert Irving Comprehensive Cancer Center (HICCC) and Columbia Stem Cell Initiative (CSCI), Columbia University, New York, NY, U.S.A.;Department of Hepato-Biliary-Pancreatic and Gastrointestinal Surgery, International University of Health and Welfare MITA Hospital, Tokyo, Japan. ^[4] Department of Disaster and Emergency and Critical Care Medicine, Kobe University Graduate School of Medicine, Kobe, Japan. ^[5] Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan.;Department of Microbiology, Kindai University Faculty of Medicine, Osaka, Japan. ^[6]

关键词 Esophageal cancer cancer stem cell chemoresistance predictor neoadjuvant chemotherapy